Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions. Limited documentation.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1969
Report date:
1969

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
limited documentation
Principles of method if other than guideline:
Study performed before actual guideline was established.
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Test animals

Species:
rat
Strain:
other: CFY
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: range 59 - 86 g
- Fasting period before study: overnight

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: unchanged and water, respectively
Details on oral exposure:
- Amount of vehicle (if gavage): 0, 1.6, 2.5, 3.2, 4.0, 5.0, 8.0 ml/kg bw of test substance (aqueous solution)
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg bw (in the report stated as minimum volume-dosage, which very likely must be a typing error)
Doses:
0, 1.6, 2.5, 3.2, 4.0, 5.0, 8.0 ml/kg bw (approximately equivalent to mg/kg bw)
No. of animals per sex per dose:
5
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations several times on the day of application; weighing at dosing and weekly thereafter
- Necropsy of survivors performed: yes
- Other examinations performed: mortality, time to death, clinical signs, body weight
Statistics:
From the mortality data the LD50 value and its 95 % confidence limits were calculated by the method of Litchfield and Wilcoxon (1949).

Results and discussion

Preliminary study:
Range finder with 1 animal per sex and dose at dosages of 0, 5.0 and 10 ml/kg bw indicated a median lethal dose (LD50) in the region of 5 ml/kg bw. Subsequently dosing was extended to groups of 5/sex/dose in order to locate the LD50 more precisely.
Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 202.5 mg/kg bw
Based on:
test mat.
95% CL:
2 775.5 - 3 629.5
Remarks on result:
other: calculated from 3 mL/kg bw based on the density of 1.0675 g/cm³
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 mL/kg bw
Based on:
test mat.
95% CL:
2.6 - 3.4
Mortality:
Males:
8.0 ml/kg: 5/5 (after 5 - < 22 h)
5.0 ml/kg: 5/5 (after 5 - < 22 h)
4.0 ml/kg: 5/5 (after < 21 h)
3.2 ml/kg: 2/5 (after < 22 h)
2.5 ml/kg: 0/5
1.6 ml/kg: 0/5
control: 0/5

Females:
8.0 ml/kg: 5/5 (after < 22 h)
5.0 ml/kg: 5/5 (after < 22 h)
4.0 ml/kg: 4/5 (after < 21 h)
3.2 ml/kg: 4/5 (after < 22 - 24 h)
2.5 ml/kg: 2/5 (after < 23 - 27 h)
1.6 ml/kg: 0/5
control: 0/5
Clinical signs:
other: Lethargy and diuresis were observed at dosages of 3.2 ml/kg bw or more. Death was preceded by ataxia and coma and usually occurred within 5 to 27 hours following dosing. Recovery of the survivors was apparently complete five days after dosing, as judged
Gross pathology:
The deceased animals showed inflammation of the intestines which were devoid of solid content. The autopsies of the survivors revealed no treatment-related findings.

Any other information on results incl. tables

Conclusion:

The findings in the deceased animals demonstrate mortality due to local irritant effects in form of gastro-intestinal inflammation rather than systemic toxicity. According to the criteria of the DSD and the CLP regulation the substance does not have to be classified for acute oral toxicity.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
CLP: not classified
DSD: not classified